z-logo
open-access-imgOpen Access
Indels, structural variation, and recombination drive genomic diversity in Plasmodium falciparum
Author(s) -
Alistair Miles,
Zamin Iqbal,
P. Vauterin,
Richard D. Pearson,
Susana Campino,
Michel Theron,
Kelda Gould,
Daniel G. Mead,
Eleanor Drury,
John O’Brien,
Valentín Ruano Rubio,
Bronwyn MacInnis,
Jonathan Mwangi,
Upeka Samarakoon,
Lisa RanfordCartwright,
Michael T. Ferdig,
Karen Hayton,
Xinzhuan Su,
Thomas E. Wellems,
Julian C. Rayner,
Gil McVean,
Dominic Kwiatkowski
Publication year - 2016
Publication title -
genome research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.556
H-Index - 297
eISSN - 1549-5469
pISSN - 1088-9051
DOI - 10.1101/gr.203711.115
Subject(s) - biology , indel , genetics , genome , single nucleotide polymorphism , genome evolution , snp , evolutionary biology , genotype , gene
The malaria parasite Plasmodium falciparum has a great capacity for evolutionary adaptation to evade host immunity and develop drug resistance. Current understanding of parasite evolution is impeded by the fact that a large fraction of the genome is either highly repetitive or highly variable and thus difficult to analyze using short-read sequencing technologies. Here, we describe a resource of deep sequencing data on parents and progeny from genetic crosses, which has enabled us to perform the first genome-wide, integrated analysis of SNP, indel and complex polymorphisms, using Mendelian error rates as an indicator of genotypic accuracy. These data reveal that indels are exceptionally abundant, being more common than SNPs and thus the dominant mode of polymorphism within the core genome. We use the high density of SNP and indel markers to analyze patterns of meiotic recombination, confirming a high rate of crossover events and providing the first estimates for the rate of non-crossover events and the length of conversion tracts. We observe several instances of meiotic recombination within copy number variants associated with drug resistance, demonstrating a mechanism whereby fitness costs associated with resistance mutations could be compensated and greater phenotypic plasticity could be acquired.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom